Mayo Clinical Cancer Center (MCCC)

Rochester, Minnesota 55905

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Multiple Myeloma

Studies at this site

• Study Evaluating Safety and Efficacy of UCART Targeting CS1 in Patients With Relapsed/Refractory Multiple Myeloma (MELANI-01) — Stopped early